CONTEXT: A story broke last year about COVID detection in sewage, as agencies tried to understand the scale and spread of the pandemic. This article follows up on that story Continue Reading
CONTEXT: Another commercial announcement from Verantos. Regular readers will remember them inking a deal back in March with Amgen to launch an advanced RWE program focused on “high-validity” observational studies. Continue Reading
CONTEXT: I know we are preaching to the converted, but great to see the NEJM publishing a CDC study that underlines how important RWE can be in guiding decisions, even Continue Reading
CONTEXT: Another RWR study showing deficiencies in available biomarker testing, this time in Chronic lymphatic leukaemia patients. Biomarker driven care will give better outcomes for those patients with specific mutations Continue Reading
CONTEXT: A different approach to spotting early onset dementia, utilising driving behaviour from a 4 year period in the US. As a long-term advocate of better diagnostic tools in dementia Continue Reading
CONTEXT: “Data monetisation in the Med Tech environment”. I have to be honest – I’ve read this article twice and still not entirely sure what this actually means in real Continue Reading
CONTEXT: Commercial announcement of a study conducted in the Real-world on a HCV test. Small numbers of patients involved and no details of the research, so by way of caution, Continue Reading
CONTEXT: Novrtis going old school with the announcement of a global Phase 3b study in children with spinal muscular atrophy (SMA). Respect to Novartis for making the announcement and calling Continue Reading
CONTEXT: A very well put together and clearly well researched opinion piece promoting RWD as the basis for COVID decision making in the US. Interesting highlight of what is termed Continue Reading
CONTEXT: Commercial announcement of an RWE report updated for 2020 to 2030 claiming to cover a wide range of information about providers of RWE services and future trends in RWE. Continue Reading
